+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asuragen Inc - Product Pipeline Analysis, 2020 Update

  • ID: 4267328
  • Company Profile
  • June 2020
  • 31 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abazyme LLC
  • Verax Biomedical Inc
  • MORE
Summary

Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that offers laboratory medicine solutions. The company's products include amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It offers diagnostic products for use in clinical laboratories and bio/pharma partners’ diagnostic needs. The company distributes its products across Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Asuragen Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abazyme LLC
  • Verax Biomedical Inc
  • MORE
Asuragen Inc Company Overview
  • Asuragen Inc Company Snapshot
  • Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Asuragen Inc – Pipeline Analysis Overview
  • Asuragen Inc - Key Facts
  • Asuragen Inc - Major Products and Services
  • Asuragen Inc Pipeline Products by Development Stage
Asuragen Inc Pipeline Products Overview
  • Companion Diagnostic Test - Huntington's Disease
  • Companion Diagnostic Test - Huntington's Disease Product Overview
  • Diagnostic Test - Neurodegenerative Disorders
  • Diagnostic Test - Neurodegenerative Disorders Product Overview
  • Diagnostic Test - Spinal Muscular Atrophy
  • Diagnostic Test - Spinal Muscular Atrophy Product Overview
  • Immunomagnetic Micro-Aperture Chip System
  • Immunomagnetic Micro-Aperture Chip System Product Overview
  • miRNA Based Sequencing Test - Colon Cancer
  • miRNA Based Sequencing Test - Colon Cancer Product Overview
  • miRNA Based Sequencing Test - Esophageal Cancer
  • miRNA Based Sequencing Test - Esophageal Cancer Product Overview
  • miRNA Based Sequencing Test - Lung Cancer
  • miRNA Based Sequencing Test - Lung Cancer Product Overview
  • miRNA Based Sequencing Test - Pancreatic Cancer
  • miRNA Based Sequencing Test - Pancreatic Cancer Product Overview
  • Signature CF Expand
  • Signature CF Expand Product Overview
  • Asuragen Inc - Key Competitors
  • Asuragen Inc - Key Employees
  • Asuragen Inc - Locations And Subsidiaries
  • Head Office
Recent Developments
  • Asuragen Inc, Recent Developments
  • Mar 16, 2020: Asuragen develops RNA Quant technology for coronavirus assays
  • Feb 24, 2020: FDA grants marketing authorisation for Fragile X Syndrome test
  • Nov 26, 2019: Asuragen and Wave Life Sciences to create diagnostics for Huntington's
  • Nov 06, 2019: Asuragen announces launch of AmplideX PCR/CE SMN1/2 Plus Kit
  • Oct 30, 2019: Asuragen to present at 2019 Association for Molecular Pathology (AMP) Annual Meeting
  • Oct 08, 2019: Asuragen to present at the 2019 American Society of Human Genetics (ASHG) Annual Meeting
  • Jun 11, 2019: Asuragen to present at 2019 European Society of Human Genetics (ESHG) Conference
  • Jun 04, 2019: Asuragen NGS System streamlines detection of NSCLC-associated DNA mutations, gene fusions, and RNA expression targets in single workflow
  • May 02, 2019: Asuragen announce the launch of AmplideX PCR/CE HTT kit for Huntington’s disease
  • Apr 02, 2019: Asuragen releases updated AmplideX PCR/CE Reporter Software
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Asuragen Inc Pipeline Products by Equipment Type
  • Asuragen Inc Pipeline Products by Indication
  • Asuragen Inc, Key Facts
  • Asuragen Inc, Major Products and Services
  • Asuragen Inc Number of Pipeline Products by Development Stage
  • Asuragen Inc Pipeline Products Summary by Development Stage
  • Companion Diagnostic Test - Huntington's Disease - Product Status
  • Companion Diagnostic Test - Huntington's Disease - Product Description
  • Diagnostic Test - Neurodegenerative Disorders - Product Status
  • Diagnostic Test - Neurodegenerative Disorders - Product Description
  • Diagnostic Test - Spinal Muscular Atrophy - Product Status
  • Diagnostic Test - Spinal Muscular Atrophy - Product Description
  • Immunomagnetic Micro-Aperture Chip System - Product Status
  • Immunomagnetic Micro-Aperture Chip System - Product Description
  • miRNA Based Sequencing Test - Colon Cancer - Product Status
  • miRNA Based Sequencing Test - Colon Cancer - Product Description
  • miRNA Based Sequencing Test - Esophageal Cancer - Product Status
  • miRNA Based Sequencing Test - Esophageal Cancer - Product Description
  • miRNA Based Sequencing Test - Lung Cancer - Product Status
  • miRNA Based Sequencing Test - Lung Cancer - Product Description
  • miRNA Based Sequencing Test - Pancreatic Cancer - Product Status
  • miRNA Based Sequencing Test - Pancreatic Cancer - Product Description
  • Signature CF Expand - Product Status
  • Signature CF Expand - Product Description
  • Asuragen Inc, Key Employees
  • Glossary
List of Figures
  • Asuragen Inc Pipeline Products by Equipment Type
  • Asuragen Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3
  • Verax Biomedical Inc
  • Aviva Systems Biology Corp
  • Abazyme LLC
Note: Product cover images may vary from those shown
Adroll
adroll